These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 33281825)

  • 1. Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy.
    Kirtland ME; Tsitoura DC; Durham SR; Shamji MH
    Front Immunol; 2020; 11():599083. PubMed ID: 33281825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors as targets for allergen immunotherapy.
    Aryan Z; Rezaei N
    Curr Opin Allergy Clin Immunol; 2015 Dec; 15(6):568-74. PubMed ID: 26418475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and mechanisms of immunotherapy in allergic rhinitis and asthma.
    Kappen JH; Durham SR; Veen HI; Shamji MH
    Ther Adv Respir Dis; 2017 Jan; 11(1):73-86. PubMed ID: 27678500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
    Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
    Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new era of targeting the ancient gatekeepers of the immune system: toll-like agonists in the treatment of allergic rhinitis and asthma.
    Aryan Z; Holgate ST; Radzioch D; Rezaei N
    Int Arch Allergy Immunol; 2014; 164(1):46-63. PubMed ID: 24853609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers.
    Shamji MH; Durham SR
    J Allergy Clin Immunol; 2017 Dec; 140(6):1485-1498. PubMed ID: 29221580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor ligands as adjuvants in allergen-specific immunotherapy.
    Johansen P; Senti G; Martinez Gomez JM; Storni T; von Beust BR; Wüthrich B; Bot A; Kündig TM
    Clin Exp Allergy; 2005 Dec; 35(12):1591-8. PubMed ID: 16393325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper.
    Shamji MH; Kappen JH; Akdis M; Jensen-Jarolim E; Knol EF; Kleine-Tebbe J; Bohle B; Chaker AM; Till SJ; Valenta R; Poulsen LK; Calderon MA; Demoly P; Pfaar O; Jacobsen L; Durham SR; Schmidt-Weber CB
    Allergy; 2017 Aug; 72(8):1156-1173. PubMed ID: 28152201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International consensus on allergy immunotherapy.
    Jutel M; Agache I; Bonini S; Burks AW; Calderon M; Canonica W; Cox L; Demoly P; Frew AJ; O'Hehir R; Kleine-Tebbe J; Muraro A; Lack G; Larenas D; Levin M; Nelson H; Pawankar R; Pfaar O; van Ree R; Sampson H; Santos AF; Du Toit G; Werfel T; Gerth van Wijk R; Zhang L; Akdis CA
    J Allergy Clin Immunol; 2015 Sep; 136(3):556-68. PubMed ID: 26162571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse immune mechanisms of allergen immunotherapy for allergic rhinitis with and without asthma.
    Shamji MH; Sharif H; Layhadi JA; Zhu R; Kishore U; Renz H
    J Allergy Clin Immunol; 2022 Mar; 149(3):791-801. PubMed ID: 35093483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. House dust mite allergy: Its innate immune response and immunotherapy.
    Huang FL; Liao EC; Yu SJ
    Immunobiology; 2018 Mar; 223(3):300-302. PubMed ID: 29079219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mannoside-glycocluster adjuvant: Compared in vitro to CpG ODN and MPL and tested in vivo in mouse asthma model.
    Mäkinen K; Mukherjee C; Leino M; Panchadhayee R; Lehto M; Wolff H; Alenius H; Leino R; Savolainen J
    Allergol Immunopathol (Madr); 2016; 44(1):9-17. PubMed ID: 26395525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy and asthma.
    Tosca MA; Olcese R; Licari A; Ciprandi G
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():46-48. PubMed ID: 32017211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy in allergic rhinitis: current use and future trends.
    Klimek L; Pfaar O; Bousquet J; Senti G; Kündig T
    Expert Rev Clin Immunol; 2017 Sep; 13(9):897-906. PubMed ID: 28532268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of Allergen Immunotherapy and Its Clinical Application in China: Contrasts and Comparisons with the USA.
    Guan K; Liu B; Wang M; Li Z; Chang C; Cui L; Wang RQ; Wen LP; Leung PSC; Wei JF; Sun JL
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):128-143. PubMed ID: 31243705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Functional IgE-Blocking Factor Induced by Allergen-Specific Immunotherapy Correlates with IgG4 Antibodies and a Decrease of Symptoms in House Dust Mite-Allergic Children.
    Zhao D; Lai X; Tian M; Jiang Y; Zheng Y; Gjesing B; Zhong N; Spangfort MD
    Int Arch Allergy Immunol; 2016; 169(2):113-20. PubMed ID: 27049773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
    Virkud YV; Wang J; Shreffler WG
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responders and nonresponders to pharmacotherapy and allergen immunotherapy.
    Jakalski M; Bozek A; Canonica GW
    Hum Vaccin Immunother; 2019; 15(12):2896-2902. PubMed ID: 31070995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.